Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Depreciation & Amortization (CF): 2023-2024

Historic Depreciation & Amortization (CF) for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $32,000.

  • CG Oncology's Depreciation & Amortization (CF) rose 1880.95% to $416,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $617,000, marking a year-over-year increase of 1613.89%. This contributed to the annual value of $32,000 for FY2024, which is 88.24% up from last year.
  • As of FY2024, CG Oncology's Depreciation & Amortization (CF) stood at $32,000, which was up 88.24% from $17,000 recorded in FY2023.
  • CG Oncology's Depreciation & Amortization (CF)'s 5-year high stood at $32,000 during FY2024, with a 5-year trough of $17,000 in FY2023.
  • Moreover, its 2-year median value for Depreciation & Amortization (CF) was $24,500 (2023), whereas its average is $24,500.
  • Data for CG Oncology's Depreciation & Amortization (CF) shows a peak YoY surged of 88.24% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Depreciation & Amortization (CF) stood at $17,000 in 2023, then spiked by 88.24% to $32,000 in 2024.